fbpx
Human Genome Editing - EmbryoClinic
At EMBRYOCLINIC we join forces to provide quality of care and fertility services customized to our patients. We are committed to effectiveness, safety and excellence. EmbryoClinic’s Medical Team was established in 1999 and its extensive experience is a guarantee for success in an ethical and safe environment. Cutting edge medical technology is used and current medical protocols applied in accordance to the latest international guidelines.
fertility, infertility, female fertility, male fertility, female infertility, male infertility, boost your fertility, Endometriosis, Pelvic infection, ovarian surgery, Irregular menstrual cycle, amenorrhoea, Chronic testicular pain, hormonal evaluation, semen analysis, Intrauterine insemination, IUI, IVF, in vitro fertilisation, Assisted Reproduction, Ovulation induction, STAGES OF IVF, Intracytoplasmic Sperm Injection, ICSI, Assisted Hatching, AH, Percutaneous Epidydimal Sperm Aspiration, PESA, Testicular Sperm Extraction, TESE, Preimplantation Genetic Diagnosis, PGD, Donor Eggs, ecoIVF, mini IVF, Natural cycle IVF, mild stimulation IVF, Egg Sharing, Fertility preservation, SPERM DONATION, EGG DONATION, HOLISTIC APPROACH, fertility massage, fertility nutrition, fertility acupuncture
27317
post-template-default,single,single-post,postid-27317,single-format-standard,cookies-not-set,ajax_fade,page_not_loaded,,select-child-theme-ver-4.4.1533193858,select-theme-ver-4.4,wpb-js-composer js-comp-ver-5.7,vc_responsive

Human Genome Editing

In 1978, Louise Brown was the first baby born through In Vitro Fertilisation (IVF). Whereas suspicion, hostility and fear of the consequences were triggered by the announcement of her birth, it brought hope to millions of couples. IVF is now an established technique worldwide and a lot of progress on safety standards and efficiency rates has been made since then.

Forty years, and millions of babies later, He Jiankui, a Chinese scientist, announced the birth of twin girls with edited genomes. Genome editing refers to the correction of specific mutations within the genome for therapeutic applications. This announcement has created shockwaves throughout the scientific community and curiosity to the public. A new debate has just begun.

Jiankui claimed that he used the CRISPR genome editing technology in order to modify the genome of the embryos and make them resistant to HIV. Now he is facing widespread condemnation because, not only did he break national laws by editing genes for reproductive purposes, but moreover it is unclear if the technique he used could have caused extra, unwanted changes elsewhere in an individuals’ DNA. Thus the question: Do CRISPR’s benefits outweigh the risks?

It is possible that, in the future, parents who have or carry a monogenic heritable disease (such as cystic fibrosis) will be able to conceive a healthy child through IVF and CRISPR genome editing technology. However, there is a lot of concern about germline genome editing, as any modifications will be inherited to next generations, creating effects difficult to reverse. The consequences are impossible to predict.  Therefore, it is of paramount importance that this fascinating and powerful technology be regulated by international legislature, taking all ethical considerations into account.

CRISPR promises to change the way we address genetic diseases, however, it will take decades of research before this remarkable genome editing technology can be used safely. At Embryoclinic, we follow with interest the improvements on this fast-moving field and we believe that the most exciting advances are yet to come. Nevertheless, it is essential for us to ensure that these and other cutting-edge techniques be applied with safety and efficiency.